Short description
Cortria Corporation, a pharmaceutical company, develops medicines for the treatment of cardiovascular diseases.
Description
Cortria Corporation, a pharmaceutical company, develops medicines for the treatment of cardiovascular diseases. Its product is used for the treatment of dyslipidemia, an atherogenic disorder characterized by abnormal lipid levels in the bloodstream. The company was founded in 2005 and is based in Boston, Massachusetts. As of August 24, 2010, Cortria Corporation operates as a subsidiary of DERMENA North America Inc.
Total funding
$$3123123
Sign in for full access
Location
Boston, Massachusetts, United States, North America
Founded on
January 1, 2005
Non-profit?
No
Acquired?
No
Employees count
1-10
Revenue range
$7890 - 12340
Sign in for full access